✦ LIBER ✦

Vaccine therapy in non—small-cell lung cancer

✍ Scribed by Carol Albright; Jennifer Garst

Publisher: Current Science Inc.
Year: 2007
Tongue: English
Weight: 233 KB
Volume: 9
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-007-0029-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapy of non-small cell lung

Adjuvant therapy of non-small cell lung cancer

✍ E. Carmack Holmes 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

One hundred and forty thousand patients in the United States will develop lung cancer annually. About one half of these will have disease confined to the thorax with no clinical evidence of dissemination (Figure 1). A relatively high proportion of these patients will actually have disease that can b

Gefitinib therapy for non-small cell lun

Gefitinib therapy for non-small cell lung cancer

✍ Ariel Birnbaum; Neal Ready 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 190 KB

Adjuvant therapy in completely resected

Adjuvant therapy in completely resected non-small-cell lung cancer

✍ Giorgio V. Scagliotti; Silvia Novello 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 410 KB

Non-small cell lung cancer

✍ M. Dediu; W. Hilbe 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 132 KB

Recent advances in etoposide therapy for

Recent advances in etoposide therapy for non-small cell lung cancer

✍ Philip Bonomi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of

Second-line therapy for advanced non-sma

Second-line therapy for advanced non-small-cell lung cancer

✍ Christine L. Hann; Julie R. Brahmer 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 90 KB